Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immune system via cell-contact and paracrine signaling is a broad physiological category describing the primary modes of communication between immune cells. Cell-contact signaling, or juxtacrine signaling, requires direct physical interaction between membrane-bound proteins, such as the binding of T-cell receptors to MHC-peptide complexes on antigen-presenting cells (Murphy & Weaver, Janeway's Immunobiology, 2016). Paracrine signaling involves the secretion of short-range soluble factors, primarily cytokines and chemokines, which bind to receptors on neighboring cells to elicit specific biological responses (Alberts et al., Molecular Biology of the Cell, 2002). These communication channels are vital for the spatial and temporal coordination of the immune system, including the recruitment of leukocytes to sites of infection and the regulation of inflammatory intensity (Abbas et al., Cellular and Molecular Immunology, 2017). Dysregulation of these signaling networks is central to the pathogenesis of autoimmune diseases, chronic inflammation, and the establishment of the tumor microenvironment. Because this term encompasses a vast array of distinct molecular interactions rather than a single protein or gene product, it is not considered a discrete therapeutic target. Instead, drug development focuses on specific nodes within this system, such as checkpoint inhibitors or cytokine-neutralizing antibodies, to achieve therapeutic effects.
Not applicable as this is a biological process/system, not a single molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune system via cell-contact and paracrine signaling.